| Micro-ELISA
Array Researchers at the Spendlove Research Foundation (SRF) have developed a Micro-ELISA array that allows researchers to simultaneously quantify multiple analyte concentrations in serum or other solutions. The current Micro-ELISA array simultaneously tests up to 24 different analytes using a 3 microliter serum sample in a single well of a 96 well microtiter plate. The Micro-ELISA array allows researchers to obtain as many as 2112 data points – each point representing a quantitative sandwich ELISA. Up to 88 wells of the 96 well plate may be used for similar assays. The remaining eight wells are used for standard controls and standard curve generation. For more details, view a Powerpoint presentation on the Micro-ELISA array. Custom Assay Development Services Custom assay development services are available from Spendlove Research Foundation. Our scientists need only antibodies and purified antigen to develop an assay for a specific analyte. If you would be interested in having a Micro-ELISA developed for your specific needs, please let us know. We have developed a highly efficient system to keep costs low. You may be surprised at how little new assays cost to develop and run. Please contact us for pricing and more information. Cancer Marker Status Our current research efforts include the development of a Micro-ELISA array for simultaneously assaying multiple cancer markers including PSA, Free PSA, PSA/ACT, PAP, NSE, AFP, TGF-Beta, Ferritin, hCG, hTG, IL-2, IL-6, S100-B, CA 15-3, CA19-9, CA125, Beta 2 Microglobulin, Alpha 2 Macroglobulin, CEA. Other cancer and general health markers are being added to the system each week. This Micro-ELISA cancer array system has not yet been approved by the FDA. It is for research use only and should not be used for diagnosis, screening or monitoring of a disease state in patients. Current Cancer Marker Assays |
